The decision tree: matching drug names to your treatment goal Use this decision tree to identify which GLP-1 medication class aligns with your treatment goal
Data in the literature support the hypothesis that GIP promotes fat deposition, and in vitro experiments on GIP-R-deficient show a resistance to obesity ( 1.3 In vitro Tirzepatides effects In vivo and in vitro preclinical studies have demonstrated that co-administration of GIP and GLP1 promotes insulin sensitivity, leading to better blood glucose level control, more sustained reduction in food intake and consequently better WL compared to the infusion of a single agent (35, 41, 46), also exerts an additive effect on metabolism of cyclic adenosine monophosphate (cAMP), thus increasing its levels and consequently, potentiating insulin secretion glucose-dependent
30-60 minutes before training
The best thing you can do right now is track your tirzepatide outcomes carefully, know your cardiovascular baseline, and have a specific conversation with your prescriber about your plateau status
The result is not a health risk, but it is a real aesthetic concern and one that catches many patients off guard